Seattle startup Cyrus Biotechnology is spinning out a business that will expand access to the company’s software technology, with the potential of supporting innovation in drug development, agriculture, synthetic biology… Read More
Seattle-based Cyrus Biotechnology says it’ll collaborate with the Broad Institute of MIT and Harvard on ways to optimize CRISPR gene-editing techniques for use in developing novel human therapeutics. CRISPR has… Read More
There’s a lot of movement in Amazon’s vast world of entertainment, gaming and audio programming, with industry veterans coming in and going out at Amazon Game Studios, Amazon Studios and… Read More
MicroVision, the Redmond, Wash.,-based maker of laser projection technology, is under new leadership. The company announced that longtime technology executive Perry Mulligan is taking over the CEO role, replacing former… Read More
Cyrus Biotechnology is getting an $8 million infusion for its cloud-based protein modeling and design toolkit, thanks to a Series A financing round. The investment round was led by Trinity… Read More
Synthetic genomes and gene editing are big things today, but the next big things in biotechnology could be proteins that are designed and edited on computers – and are then synthesized… Read More
CoMotion at the University of Washington is licensing the Rosetta protein design software to Cyrus Biotechnology, which plans to create a more user-friendly version of the program. Cyrus Biotech recently raised $850,000 and today’s… Read More
